{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:28:31Z","timestamp":1773700111285,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22893-4","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:55:49Z","timestamp":1762437349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DEFB4A\/hBD2, a non-invasive serum biomarker for detection of ulcerative colitis"],"prefix":"10.1038","volume":"15","author":[{"given":"Soumyabrata","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anannya","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susree","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeya","family":"Roychowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antara","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopal Krishna","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arka","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"22893_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s, I., Eckmann, L., Talamini, M., Baumgart, D. C. & Sandborn, W. J. Ulcerative colitis. Lancet 380, 1606\u20131619 (2012).","journal-title":"Lancet"},{"key":"22893_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/j.1440-1746.2011.06890.x","volume":"26","author":"T Watanabe","year":"2011","unstructured":"Watanabe, T., Hirono, H., Hasegawa, K., Soga, K. & &Shibasaki, K. Literature review in cases with exacerbation of ulcerative colitis induced by treatment with interferon and\/or ribavirin. J. Gastroenterol. Hepatol. 26, 1709\u20131716 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"22893_CR3","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.3748\/wjg.v22.i21.5079","volume":"22","author":"A Nakarai","year":"2016","unstructured":"Nakarai, A. et al. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse. World J. Gastroenterol. 22, 5079\u20135087 (2016).","journal-title":"World J. Gastroenterol."},{"key":"22893_CR4","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.3748\/wjg.14.3937","volume":"14","author":"PL Lakatos","year":"2008","unstructured":"Lakatos, P. L. & Lakatos, L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 14, 3937\u20133947 (2008).","journal-title":"World J. Gastroenterol."},{"key":"22893_CR5","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.3390\/curroncol29090479","volume":"29","author":"W Li","year":"2022","unstructured":"Li, W. et al. Colorectal cancer in ulcerative colitis: mechanisms, surveillance and chemoprevention. Curr. Oncol. 29, 6091\u20136114 (2022).","journal-title":"Curr. Oncol."},{"key":"22893_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Primers. 6, 74 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"22893_CR7","doi-asserted-by":"publisher","first-page":"G981","DOI":"10.1152\/ajpgi.00309.2014","volume":"308","author":"JA Rodr\u00edguez-Feo","year":"2015","unstructured":"Rodr\u00edguez-Feo, J. A. et al. A new role for reticulon-4B\/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G981\u2013G993 (2015).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"22893_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","volume":"13","author":"AJ Walsh","year":"2016","unstructured":"Walsh, A. J., Bryant, R. V. & Travis, S. P. L. Current best practice for disease activity assessment in IBD. Nat. Rev. Gastroenterol. Hepatol. 13, 567\u2013579 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"22893_CR9","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/biomedicines10071492","volume":"10","author":"Z Alghoul","year":"2022","unstructured":"Alghoul, Z., Yang, C. & Merlin, D. The current status of molecular biomarkers for inflammatory bowel disease. Biomedicines 10, 1492 (2022).","journal-title":"Biomedicines"},{"key":"22893_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner, D. et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160, 1570\u20131583 (2021).","journal-title":"Gastroenterology"},{"key":"22893_CR11","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.1038\/s41598-025-89615-8","volume":"15","author":"Y Aoyama","year":"2025","unstructured":"Aoyama, Y. et al. Changes of leucine-rich alpha 2 glycoprotein could be a marker of changes of endoscopic and histologic activity of ulcerative colitis. Sci. Rep. 15, 5248 (2025).","journal-title":"Sci. Rep."},{"key":"22893_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ajg.2015.6","volume":"110","author":"SB Menees","year":"2015","unstructured":"Menees, S. B., Powell, C., Kurlander, J., Goel, A. & Chey, W. D. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am. J. Gastroenterol. 110, 444\u2013454 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"22893_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ecco-jcc\/jjv050","volume":"9","author":"K Holgersen","year":"2015","unstructured":"Holgersen, K. et al. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. J. Crohns Colitis. 9, 492\u2013506 (2015).","journal-title":"J. Crohns Colitis"},{"key":"22893_CR14","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.3748\/wjg.v20.i13.3542","volume":"20","author":"D Guagnozzi","year":"2014","unstructured":"Guagnozzi, D. & Lucendo, A. J. Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J. Gastroenterol. 20, 3542\u20133551 (2014).","journal-title":"World J. Gastroenterol."},{"key":"22893_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12876-017-0619-4","volume":"17","author":"DH Tran","year":"2017","unstructured":"Tran, D. H. et al. Circulating Cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in crohn\u2019s disease, and clinical prognosis in inflammatory bowel disease. BMC Gastroenterol. 17, 63 (2017).","journal-title":"BMC Gastroenterol."},{"key":"22893_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1572-0241.2003.07458.x","volume":"98","author":"SV Kane","year":"2003","unstructured":"Kane, S. V. et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol. 98, 1309\u20131314 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"22893_CR17","first-page":"686","volume":"9","author":"C Greenhill","year":"2012","unstructured":"Greenhill, C. Elafin\u2014a potential IBD therapy. Nat. Rev. Gastroenterol. Hepatol. 9, 686 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"22893_CR18","doi-asserted-by":"publisher","first-page":"e0227306","DOI":"10.1371\/journal.pone.0227306","volume":"15","author":"TB Yu","year":"2020","unstructured":"Yu, T. B., Dodd, S., Yu, L. G. & Subramanian, S. Serum galectins as potential biomarkers of inflammatory bowel diseases. PLoS One. 15, e0227306 (2020).","journal-title":"PLoS One"},{"key":"22893_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/gut.47.4.506","volume":"47","author":"J Tibble","year":"2000","unstructured":"Tibble, J. et al. A simple method for assessing intestinal inflammation in crohn\u2019s disease. Gut 47, 506\u2013513 (2000).","journal-title":"Gut"},{"key":"22893_CR20","doi-asserted-by":"publisher","first-page":"e00617","DOI":"10.14309\/ctg.0000000000000617","volume":"14","author":"N Kapel","year":"2023","unstructured":"Kapel, N., Ouni, H., Benahmed, N. A. & Barbot-Trystram, L. Fecal calprotectin for the diagnosis and management of inflammatory bowel diseases. Clin. Transl Gastroenterol. 14, e00617 (2023).","journal-title":"Clin. Transl Gastroenterol."},{"key":"22893_CR21","doi-asserted-by":"publisher","first-page":"18243","DOI":"10.1038\/s41598-021-97366-5","volume":"11","author":"B Linggi","year":"2021","unstructured":"Linggi, B. et al. Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis. Sci. Rep. 11, 18243 (2021).","journal-title":"Sci. Rep."},{"key":"22893_CR22","doi-asserted-by":"publisher","first-page":"9962","DOI":"10.1038\/s41598-022-14048-6","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods. Sci. Rep. 12, 9962 (2022).","journal-title":"Sci. Rep."},{"key":"22893_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","volume":"164","author":"S Singh","year":"2023","unstructured":"Singh, S. et al. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology 164, 344\u2013372 (2023).","journal-title":"Gastroenterology"},{"issue":"7","key":"22893_CR24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"22893_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 (5), 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"22893_CR26","doi-asserted-by":"publisher","first-page":"175628482412516","DOI":"10.1177\/17562848241251600","volume":"17","author":"J Clough","year":"2024","unstructured":"Clough, J., Colwill, M., Poullis, A., Pollok, R. & Patel, K. &Honap, S. Biomarkers in inflammatory bowel disease: a practical guide. Ther. Adv. Gastroenterol. 17, 17562848241251600 (2024).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"22893_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12876-016-0535-z","volume":"16","author":"MA Mendall","year":"2016","unstructured":"Mendall, M. A., Chan, D., Patel, R. & Kumar, D. Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of crohn\u2019s disease. BMC Gastroenterol. 16, 126 (2016).","journal-title":"BMC Gastroenterol."},{"key":"22893_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/clinchem\/hvad051","volume":"69","author":"J Murray","year":"2023","unstructured":"Murray, J., Kok, K. B. & Ayling, R. M. Fecal calprotectin in Gastrointestinal disease. Clin. Chem. 69, 699\u2013710 (2023).","journal-title":"Clin. Chem."},{"key":"22893_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1248\/bpb.26.753","volume":"26","author":"S Yui","year":"2003","unstructured":"Yui, S., Nakatani, Y., Mikami, M. & Calprotectin S100A8\/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26, 753\u2013760 (2003).","journal-title":"Biol. Pharm. Bull."},{"key":"22893_CR30","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.4254\/wjh.v14.i11.1964","volume":"14","author":"C Matiollo","year":"2022","unstructured":"Matiollo, C. et al. Elevated calprotectin. World J. Hepatol. 14, 1964\u20131976 (2022).","journal-title":"World J. Hepatol."},{"key":"22893_CR31","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1038\/s41598-020-61094-z","volume":"10","author":"A Havelka","year":"2020","unstructured":"Havelka, A. et al. Calprotectin, a new biomarker for diagnosis of acute respiratory infections. Sci. Rep. 10, 4208 (2020).","journal-title":"Sci. Rep."},{"key":"22893_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3399\/bjgp16X685813","volume":"66","author":"M Cohen","year":"2016","unstructured":"Cohen, M. Proton pump inhibitors May cause elevation in faecal calprotectin levels. Br. J. Gen. Pract. 66, 350 (2016).","journal-title":"Br. J. Gen. Pract."},{"issue":"Suppl. 1","key":"22893_CR33","first-page":"i1226","volume":"18","author":"L Crothers-Stomps","year":"2024","unstructured":"Crothers-Stomps, L. et al. Faecal calprotectin determines non-response to corticosteroids in patients with immune checkpoint inhibitor colitis. J. Crohn\u2019s Colitis. 18 (Suppl. 1), i1226\u2013i1227 (2024).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"22893_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","volume":"19","author":"E Klingberg","year":"2017","unstructured":"Klingberg, E. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arthritis Res. Ther. 19, 21 (2017).","journal-title":"Arthritis Res. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22893-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22893-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:55:50Z","timestamp":1762437350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22893-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22893"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22893-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6544404\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38949"}}